Quick Takeaways
- VIKING GLOBAL INVESTORS LP filed SCHEDULE 13D/A for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO).
- Disclosed ownership: 6.1%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"VIKING GLOBAL INVESTORS LP disclosed 6.1% ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2) | 0001103804 |
| Viking Global Opportunities Parent GP LLC | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of Viking Global Opportunities Parent GP LLC (1)(2) | 0001886738 |
| Viking Global Opportunities GP LLC | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of Viking Global Opportunities GP LLC (1)(2) | 0001629476 |
| Viking Global Opportunities Portfolio GP LLC | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of Viking Global Opportunities Portfolio GP LLC (1)(2) | 0001629472 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP (1)(2) | 0001629482 |
| HALVORSEN OLE ANDREAS | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of HALVORSEN OLE ANDREAS (1) | 0001133006 |
| Shabet Rose Sharon | 6.1% | 11,842,434 | 0 | 11,842,434 | /s/ Scott M. Hendler | Scott M. Hendler on behalf of Shabet Rose Sharon (2) | 0001711393 |